InnovoTEX
Austin, US · Founded 2022
BiotechHealthtech
Founders & leadership
JS
Jonathan SesslerDirector
KK
Krystle KarosikExecutive Officer
JA
Joseph ArambulaExecutive Officer, Director
KK
Krystle KaroscikExecutive Officer, Director
JA
Jonathan ArambulaDirector
JH
James HusseyDirector
Reported raises · per SEC filings
Form D private placements▶$750KraisedAug 2026 · 14 investors · PharmaceuticalsRule 506(b)
▶$750KraisedAug 2026 · 14 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Krystle KaroscikExecutive Officer, Director
- Jonathan ArambulaDirector
- Jonathan SesslerDirector
- James HusseyDirector
- Offering amount
- $4M
- Amount sold
- $750K
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$829.8KraisedMar 2023 · 8 investors · Other Health CareRule 506(b)
▶$829.8KraisedMar 2023 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan SesslerDirector
- Krystle KarosikExecutive Officer
- Joseph ArambulaExecutive Officer, Director
- Offering amount
- $829.8K
- Amount sold
- $829.8K
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.